DocWire News Editors

DocwireNews

Antiphospholipid syndrome (APS) is a systemic autoimmune disease.&nbsp;It is characterized&nbsp;by recurrent thromboembolic events and/or morbidity in pregnancy&nbsp;in&nbsp;the presence of laboratory evidence of antiphospholipid antibodies (aPL).&nbsp;&nbsp;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Antiphospholipid Syndrome and the Lungs <a href="https://twitter.com/hashtag/Rheumatology?src=hash&amp;ref_src=twsrc%5Etfw">#Rheumatology</a> <a href="https://t.co/W2iCLrXG1b">https://t.co/W2iCLrXG1b</a>
&mdash; EMJ Rheumatology (@EMJRheum) <a href="https://twitter.com/EMJRheum/status/1010119016042680320?ref_src=twsrc%5Etfw">June 22, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Several lung manifestations may develop in patients with APS,&nbsp;including pulmonary embolism,&nbsp;thromboembolic and non-thromboembolic pulmonary hypertension,&nbsp;pulmonary&nbsp;microthrombosis, and more. Although&nbsp;pulmonary manifestations are relatively rare within the realm of&nbsp;aPL, it can happen and is more likely to be life threatening compared to other complications of&nbsp;aPL. In this article in the&nbsp;European Medical Journal, the author&nbsp;discusses the importance of early diagnosis and treatment of pulmonary manifestations,&nbsp;in order to&nbsp;improve morality rates in patients with this type of condition.&nbsp;SOURCE:&nbsp;<a href="https://www.emjreviews.com/rheumatology/article/antiphospholipid-syndrome-and-the-lungs/antiphospholipid-syndrome-and-the-lungs/">European Medical Journal&nbsp;</a>

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

What’s Lungs Got to Do With It?

Pulmonary Embolism

Antiphospholipid syndrome (APS) is a systemic autoimmune disease. It is characterized by recurrent thromboembolic events and/or morbidity in pregnancy in the presence of ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe